Dolphin
Senior Member (Voting Rights)
Link to post with link to published paper
********************
Preprint:
https://assets.researchsquare.com/f...-4a36-49f7-9a59-b63be81a30c2.pdf?c=1663177822
Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: a prospective controlled cohort study
Vegard Wyller (v.b.b.wyller@medisin.uio.no)
University of Oslo
Joel Selvakumar
Akershus University Hospital
https://orcid.org/0000-0002-9970-8011
Lise Havdal
Akershus University Hospital
Martin Drevvatne
University of Oslo
Elias Brodwall
University of Oslo
Lise Berven
University of Oslo
Tonje Stiansen-Sonerud
Akershus University Hospital
Gunnar Einvik
University of Oslo
Truls Leegaard
University of Oslo
Trygve Tjade
Fürst Medical Laboratory
Annika Michelsen
University of Oslo
Tom Mollnes
Rikshospitalet University Hospital
Fridtjof Lund-Johansen
Univ of Oslo and Oslo Univ Hospital
https://orcid.org/0000-0002-2445-1258
Trygve Holmøy
University of Oslo
Henrik Zetterberg
University of Gothenburg
https://orcid.org/0000-0003-3930-4354
Kaj Blennow
University of Gothenburg
https://orcid.org/0000-0002-1890-4193
Carolina Sandler
Western Sydney University
Erin Cvejic
The University of Sydney
Andrew Lloyd
Kirby Institute for Infection and Immunity
https://orcid.org/0000-0001-6277-8887
Article
Keywords: Long COVID, post-COVID-19 condition, post-acute sequelae of COVID-19, adolescents, SARSCoV-2, post-infective fatigue syndrome
Posted Date: September 14th, 2022
DOI: https://doi.org/10.21203/rs.3.rs-2021203/v1
Abstract
The prevalence and predictors of long COVID in young people remain unresolved. We aimed to determine the point prevalence of long COVID in non-hospitalised adolescents and young adults six months after the acute infection, to determine the risk of developing long COVID adjusted for possible confounders, and to explore a broad range of potential risk factors (prespecified outcomes).
We conducted a prospective controlled cohort study of 404 SARS-CoV-2-positive and 105 SARS-CoV-2-negative nonhospitalised individuals aged 12–25 years (ClinicalTrial ID: NCT04686734). Data acquisition was completed February 2022.
Assessments included pulmonary, cardiac and cognitive functional testing, biomarker analyses, and completion of a questionnaire, and were performed at inclusion (early convalescent stage) and six months follow-up.
The WHO case definition of long COVID was applied.
The point prevalence of long COVID at six months was 49% and 47% in the SARS-CoV-2-positive and negative group, respectively. SARS-CoV-2-positivity did not predict development of long COVID (relative risk 1.06, 95% CI 0.83 to 1.37).
The main predictor was symptom severity at inclusion, which correlated strongly to personality traits.
Low physical activity and loneliness were also predictive, while biological markers were not.
In conlusion, our study aims were met, and the findings suggest that persistent symptoms were not driven by the infection, but were associated with psychosocial factors.
********************
Preprint:
https://assets.researchsquare.com/f...-4a36-49f7-9a59-b63be81a30c2.pdf?c=1663177822
Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: a prospective controlled cohort study
Vegard Wyller (v.b.b.wyller@medisin.uio.no)
University of Oslo
Joel Selvakumar
Akershus University Hospital
https://orcid.org/0000-0002-9970-8011
Lise Havdal
Akershus University Hospital
Martin Drevvatne
University of Oslo
Elias Brodwall
University of Oslo
Lise Berven
University of Oslo
Tonje Stiansen-Sonerud
Akershus University Hospital
Gunnar Einvik
University of Oslo
Truls Leegaard
University of Oslo
Trygve Tjade
Fürst Medical Laboratory
Annika Michelsen
University of Oslo
Tom Mollnes
Rikshospitalet University Hospital
Fridtjof Lund-Johansen
Univ of Oslo and Oslo Univ Hospital
https://orcid.org/0000-0002-2445-1258
Trygve Holmøy
University of Oslo
Henrik Zetterberg
University of Gothenburg
https://orcid.org/0000-0003-3930-4354
Kaj Blennow
University of Gothenburg
https://orcid.org/0000-0002-1890-4193
Carolina Sandler
Western Sydney University
Erin Cvejic
The University of Sydney
Andrew Lloyd
Kirby Institute for Infection and Immunity
https://orcid.org/0000-0001-6277-8887
Article
Keywords: Long COVID, post-COVID-19 condition, post-acute sequelae of COVID-19, adolescents, SARSCoV-2, post-infective fatigue syndrome
Posted Date: September 14th, 2022
DOI: https://doi.org/10.21203/rs.3.rs-2021203/v1
Abstract
The prevalence and predictors of long COVID in young people remain unresolved. We aimed to determine the point prevalence of long COVID in non-hospitalised adolescents and young adults six months after the acute infection, to determine the risk of developing long COVID adjusted for possible confounders, and to explore a broad range of potential risk factors (prespecified outcomes).
We conducted a prospective controlled cohort study of 404 SARS-CoV-2-positive and 105 SARS-CoV-2-negative nonhospitalised individuals aged 12–25 years (ClinicalTrial ID: NCT04686734). Data acquisition was completed February 2022.
Assessments included pulmonary, cardiac and cognitive functional testing, biomarker analyses, and completion of a questionnaire, and were performed at inclusion (early convalescent stage) and six months follow-up.
The WHO case definition of long COVID was applied.
The point prevalence of long COVID at six months was 49% and 47% in the SARS-CoV-2-positive and negative group, respectively. SARS-CoV-2-positivity did not predict development of long COVID (relative risk 1.06, 95% CI 0.83 to 1.37).
The main predictor was symptom severity at inclusion, which correlated strongly to personality traits.
Low physical activity and loneliness were also predictive, while biological markers were not.
In conlusion, our study aims were met, and the findings suggest that persistent symptoms were not driven by the infection, but were associated with psychosocial factors.
Last edited by a moderator: